1[1]Bamford J,Sandercock P,Dennis M,et al.Classification and natural history of clinically identifiable subtypes of cerebral infarction[J].Lancet,1991,337:1521-1526.
2[2]Cloud GC,Markus HS.Diagnosis and management of vertebral artery stenosis[ J ].QJM,2003,96:27-54.
3[3]Hass WK,Fields WS,North RR,et al.Joint study of extracranial arterial occlusion.Ⅱ.Arteriography,techniques,sites,and complications[ J ].JAMA,1968,203:961-968.
4[4]Wityk RJ,Chang HM,Rosengart A,et al.Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry[ J ].Arch Neurol,1998,55:470-478.
6[6]Bauer RB,Sheehan S,Wechsler N,et al.Arteriographic study of sites,incidence,and treatment of arteriosclerotic cerebrovascular lesions[ J ].Neurology,1962,12:698-711.
7[7]Gorelick PB,Caplan LR,Hier DB,et al.Racial differences in the distribution of posterior circulation occlusive disease[J].Stroke,1985,16:785-790.
8[8]Bockeubeimer S,Reinhuber F,Mohs C.Intra-arterial thrombolysis of vessels supplying the brain[ J].Radiology,1991,31:210-215.
9[9]Trattinig S,Matula C,Karnel F,et al.Difficulties in examination of the origin of the vertebral artery by duplex and colour-coded Doppler sonography:anatomical considerations[ J ].Neuroradiology,1993,35:296-299.
10[10]Tschabitscher M,Fuss FK,Matula C,et al.Course of the arteria vertebralis in its segment V1 form the origin to its entry into the foramen processus transversi[ J ].Acta Anat(Basel),1991,140:373-377.
2[1]Wong KS. Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke.? Eur Neurol,2005, 53: 132-139.
3[2]Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke, 1995, 26: 14-20.
4[3]Frey J, Jahnke H, Bulfinch E. Difference in stroke between White, Hispanic and Native American patients.Stroke, 1998, 29: 29-33.
5[4]Feldmann E, Daneault N, Kwan E, et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology, 1990, 47: 1080-1084.
6[6]Huang YN, Gao S, Huang Y, et al. Vascular lesion in Chinese patients with transient ischemic attacks. Neurology,1997, 48: 524-525.
7[7]Wong KS, Gao S, Lam W, et al. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging, 2001, 11: 137-140.
8[8]Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta analysis. BMJ, 2002, 325: 73-74.
9[9]Smith C J, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol, 2004, 15: 2.
10[10]Nagano K, Otsubo R, Yasaka M, et al. Stroke recurrence in patients with brain embolism and patent foramen ovaleassociation with deep vein thrombosis detected by ultrasonography. Rinsho-Shinkeigaku, 2004, 44: 7-13.
